Advertisement
Advertisement
BEAT
Heartbeam, Inc. Common Stock
0.40
USDSponsored
+0.01
+1.85%
Nov 06, 15:59 UTC -5
Closed
After-Market
0.40
0.00
0.00%
Heartbeam, Inc. Common Stock (BEAT) Earnings
BEAT Earnings Reports
Positive Surprise Ratio
BEAT beat 5 of 18 last estimates.
28%
Next Report
Next Week
Date of Next Report
Nov 12, 2026
Estimate for Q3 26 (Revenue/ EPS)
$76.50K
/-$0.09
Implied change from Q2 26 (Revenue/ EPS)
--
/-10.00%
Implied change from Q3 25 (Revenue/ EPS)
--
/-40.00%
Heartbeam, Inc. Common Stock earnings per share and revenue
On Aug 13, 2026, BEAT reported earnings of -0.10 USD per share (EPS) for Q2 26, missing the estimate of -0.09 USD, resulting in a -8.93% surprise. Revenue reached --, compared to an expected 81.60 thousand, with a -100.00% difference. The market reacted with a -15.34% price change (close before vs. close after earnings).
Looking ahead to Q3 26, 5 analysts forecast an EPS of -0.09 USD, with revenue projected to reach 76.50 thousand USD, implying an decrease of -10.00% EPS, and -- of --% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Nyxoah SA Ordinary Shares
Report Date
Nov 05, 2026 For Q3 26
Estimate
-$0.30
Actual
-$0.17
Surprise
+42.29%
10x Genomics, Inc. Class A Common Stock
Report Date
Nov 05, 2026 For Q3 26
Estimate
-$0.26
Actual
-$0.15
Surprise
+43.35%
Doximity, Inc.
Report Date
Nov 05, 2026 For Q2 27
Estimate
$0.35
Actual
$0.36
Surprise
+0.56%
iRhythm Holdings, Inc. Common Stock
Report Date
Nov 05, 2026 For Q3 26
Estimate
$0.06
Actual
$0.82
Surprise
+1,214.10%
Privia Health Group, Inc. Common Stock
Report Date
Nov 05, 2026 For Q3 26
Estimate
$0.09
Actual
$0.10
Surprise
+3.73%
Enovis Corporation
Report Date
Nov 05, 2026 For Q3 26
Estimate
$0.78
Actual
$0.88
Surprise
+12.07%
Fulgent Genetics, Inc. Common Stock
Report Date
Nov 05, 2026 For Q3 26
Estimate
-$0.66
Actual
-$0.09
Surprise
+86.43%
Evolent Health, Inc Class A Common Stock
Report Date
Nov 05, 2026 For Q3 26
Estimate
$0.05
Actual
$0.06
Surprise
+13.21%
Health Catalyst, Inc Common Stock
Report Date
Nov 05, 2026 For Q3 26
Estimate
-$0.04
Actual
-$0.03
Surprise
+38.14%
Outset Medical, Inc. Common Stock
Report Date
Nov 04, 2026 For Q3 26
Estimate
-$0.71
Actual
-$0.68
Surprise
+4.78%
FAQ
What were Heartbeam, Inc. Common Stock's earnings and revenue for the latest quarter Q2 2026?
For Q2 2026, Heartbeam, Inc. Common Stock reported EPS of -$0.10, missing estimates by -8.93%, and revenue of $0.00, -100% below expectations.
How did the market react to Heartbeam, Inc. Common Stock's Q2 2026 earnings?
The stock price moved down -15.34%, changed from $0.59 before the earnings release to $0.50 the day after.
When is Heartbeam, Inc. Common Stock expected to report next?
The next earning report is scheduled for Nov 12, 2026.
What are the forecasts for Heartbeam, Inc. Common Stock's next earnings report?
Based on 5
analysts, Heartbeam, Inc. Common Stock is expected to report EPS of -$0.09 and revenue of $76.50K for Q3 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.